← Eichor
Condition: Diabetic Maculopathy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Diabetic Maculopathy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Defining Retinal Structures Using Hyperspectral Retinal Imaging
NA · 1 location(s) · Center for Eye Research Australia · NCT07555574The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma
EARLY_Phase 1 · 1 location(s) · MCPHS University · NCT06593405A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
Phase 2 · 80 location(s) · Boehringer Ingelheim · NCT06962839Proteomic Biomarker Identification in Age-Related Macular Degeneration, Diabetic Retinopathy and Retinal Detachment
NA · 1 location(s) · Fondazione G.B. Bietti, IRCCS · NCT07500324Aflibercept and Bevacizumab for Diabetic Maculopathies
Phase 4 · 1 location(s) · Al-Mustansiriyah University · NCT06850571Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin
Phase 2/Phase 3 · 1 location(s) · Isfahan University of Medical Sciences · NCT06595355A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema
Phase 3 · 1 location(s) · Incepta Pharmaceuticals Ltd · NCT06305416Village-Integrated Eye Worker Trial II
NA · 1 location(s) · University of California, San Francisco · NCT03752840Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and R
Phase N/A · 1 location(s) · Hywel Dda Health Board · NCT06914778Acute Intra Ocular Pressure Monitoring After Aflibercept 8mg/0.07mL
NA · 1 location(s) · Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer · NCT06893965Effect of Video Viewing on Intravitreal Injection Experience
NA · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07002372Serum Cholinesterases, Paraoxonase, and Cardiovascular Risk After Intravitreal Bevacizumab
Phase N/A · 1 location(s) · Ataturk University · NCT07550777Evaluating a New Peptide Therapy for Retinal Diseases: AMD, Diabetic Retinopathy, and Dystrophies
Phase 1/Phase 2 · 2 location(s) · Ace Cells Lab Limited · NCT06787482Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAION
Phase 1 · 2 location(s) · The Foundation for Orthopaedics and Regenerative Medicine · NCT05147701Analysis of Biomarkers From Patients With Chorioretinal Diseases
Phase N/A · 1 location(s) · Kyungpook National University Hospital · NCT02026843Effectiveness and Cost-Effectiveness Evaluations of AI-Assisted Diagnostic Software (VeriSee) for Ophthalmic Disease Scr
NA · 1 location(s) · National Taiwan University Hospital · NCT06843499Diagnostic Possibilities in Ophthalmological Diseases Using Swept Source Optical Coherence Tomography
Phase N/A · 1 location(s) · Johannes Kepler University of Linz · NCT06074731Artificial Intelligence-Aided Screening for Patients With Diabetic Retinopathy and Age-related Macular Degeneration in F
NA · 1 location(s) · National Taiwan University Hospital · NCT07069647Is Community Based Monitoring of Diabetic Maculopathy and Pre-proliferative Diabetic Retinopathy Safe?
NA · 1 location(s) · Hywel Dda Health Board · NCT06955611Developing and Testing a Model to Identify Preventive Vision Loss Among Older Patients in General Practice
NA · 2 location(s) · University of Copenhagen · NCT07015034Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium
EARLY_Phase 1 · 1 location(s) · MediBeacon · NCT04008121Impact of Intravitreal Faricimab on Renal Function in Diabetic Patients
NA · 2 location(s) · University Hospital, Alexandroupolis · NCT06929507MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema
Phase 1 · 3 location(s) · Shenzhen MingSight Relin Pharmaceuticals Co., Ltd. · NCT04187443Aflibercept in Recurrent or Persistent CNV
Phase N/A · 1 location(s) · Medical University of Vienna · NCT02669953"My Eyes, My Light": Amar Chokh, Amar Alo
Phase N/A · 1 location(s) · Data Yakka, Inc. · NCT07135570Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema
Phase 2 · 2 location(s) · Carmen Clapp · NCT03161652National Eye Institute Biorepository for Retinal Diseases
Phase N/A · 1 location(s) · National Eye Institute (NEI) · NCT01496625Strategies for Improving Linkage-to-Care After Eye Disease Screening
NA · 1 location(s) · University of California, San Francisco · NCT06943599A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT
Phase N/A · 1 location(s) · Nanoscope Therapeutics Inc. · NCT06805474DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. Th
Phase N/A · 1 location(s) · Bayer · NCT07308639
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.